The Mail-Order Observational Study of Experiences (MOOSE) seeks to assess the acceptability, safety, and effectiveness of telemedicine provision of medication abortion with mail-order pharmacy dispensing of mifepristone and misoprostol. Ultimately, the results of this study could improve access to legal, safe medication abortion services and expand the options for models of care for people seeking abortion.
Participants will be recruited at participating clinical sites when they present for medication abortion care. Enrolled participants will complete three online follow-up surveys: one day after receiving their medications either in-person at the clinic or by mail, and then at 14 days and 28 days after receipt of medication. Similar to our studies on brick-and-mortar and mail-order pharmacy dispensing of medication abortion, we will also collect data extracted from patients’ medical records to document follow-up care, abortion completion and any complications.
Patients obtaining medication abortion care through three care provision models (1) in-person only, (2) telemedicine/no-test protocol with mail-order delivery of medication, or (3) no-test protocol [either via telemedicine or in-person] with in-person pick up of medications at participating study sites will be eligible to participate in the study.
The results of this study may serve to improve access to legal, safe medication abortion services and expand the options for people seeking medication abortion.